Our tumor collective shows that 45% of the tumors do not express significant PD-L1 in the tumor (CPS < 1) - this is higher than in the clinical studies as described in Checkmate 649 or Keynote 859 (18% and 22%, respectively). Here, CD274 is linked to neoplasm.